Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of hepatocellular carcinoma

References

• Kalva SP, Thabet A, Wicky S. (2008). Recent advances in transarterial therapy of primary and secondary liver malignancies. Radiographics 28:101–17.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM, Lee JY, et al. (2014). Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 270:900–9.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Kimura T, Kita R, Osaki Y. (2013). Radiofrequency ablation for hepatocellular carcinoma. Int J Hyperthermia 29:558–68.
   PubMed Web of Science ®Google Scholar
• Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE. (2012). Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology 55:476–82.
   PubMed Web of Science ®Google Scholar
• Lin SM. (2009). Recent advances in radiofrequency ablation in the treatment of hepatocellular carcinoma and metastatic liver cancers. Chang Gung Med J 32:22–32.
   PubMedGoogle Scholar
• Kim JW, Kim JH, Sung KB, et al. (2014). Transarterial chemoembolization vs. radiofrequency ablation for the treatment of single hepatocellular carcinoma 2 cm or smaller. Am J Gastroenterol 2014;109:1234–40.
   Google Scholar
• Gillams ARLW. (2008). Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 19:712–7.
   PubMed Web of Science ®Google Scholar
• Hocquelet A, Balageas P, Laurent C, et al. (2015). Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: a study of 281 Western patients. Int J Hyperthermia 31:749–57.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Kornek M, Ikenaga N, et al. (2013). Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma. Hepatology 58:1667–80.
   PubMed Web of Science ®Google Scholar
• Tohme S, Geller DA, Cardinal JS, et al. (2013). Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma. HPB 15:210–7.
   PubMed Web of Science ®Google Scholar
• Pompili M, Saviano A, de Matthaeis N, et al. (2013). Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma </=3 cm. Results of a multicenter Italian survey. J Hepatol 59:89–97.
   PubMed Web of Science ®Google Scholar
• Masuda T, Beppu T, Ishiko T, et al. (2008). Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Surg 15:589–95.
   PubMedGoogle Scholar
• Mori K, Fukuda K, Asaoka H, et al. (2009). Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran-feasibility study. Radiology 251:557–65.
   PubMed Web of Science ®Google Scholar
• Kang TW, Lim HK, Lee MW, et al. (2015). Aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation: risk factors and clinical significance. Radiology 276:274–85.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Di Maso M, Muscatiello N. (2016). Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia 32:339–44.
   PubMed Web of Science ®Google Scholar
• Lu DS, Raman SS, Limanond P, et al. (2003). Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14:1267–74.
   PubMed Web of Science ®Google Scholar
• Takuma Y, Takabatake H, Morimoto Y, et al. (2013). Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology 269:927–37.
   PubMed Web of Science ®Google Scholar
• Fukuda H, Numata K, Moriya S, et al. (2014). Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation-propensity score matching analysis. Radiology 272:598–604.
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Kurokawa F, Shirahashi H, et al. (2002). Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 95:2353–60.
   PubMed Web of Science ®Google Scholar
• de Baere T, Deschamps F, Briggs P, et al. (2008). Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion. Radiology 248:1056–66.
   PubMed Web of Science ®Google Scholar
• Chen L, Sun J, Yang X. (2016). Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: current status. Cancer Lett 370:78–84.
   PubMed Web of Science ®Google Scholar
• Gerolami R, Uch R, Faivre J, et al. (2004). Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors. J Hepatol 40:291–7.
   PubMed Web of Science ®Google Scholar
• Du X, Qiu B, Zhan X, et al. (2005). Radiofrequency-enhanced vascular gene transduction and expression for intravascular MR imaging-guided therapy: feasibility study in pigs. Radiology 236:939–44.
   PubMed Web of Science ®Google Scholar
• Tiscornia G, Singer O, Verma IM. (2006). Production and purification of lentiviral vectors. Nat Prot 1:241–5.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang F, Meng Y, et al. (2013). Diffusion-weighted MRI monitoring of pancreatic cancer response to radiofrequency heat-enhanced intratumor chemotherapy. NMR Biomed 26:1762–7.
   PubMed Web of Science ®Google Scholar
• Chen L, Guo G, Liu T, et al. (2011). Radiochemotherapy of hepatocarcinoma via lentivirus-mediated transfer of human sodium iodide symporter gene and herpes simplex virus thymidine kinase gene. Nucl Med Biol 38:757–63.
   PubMed Web of Science ®Google Scholar
• Lee TY, Lin JT, Ho HJ, et al. (2015). Evaluation of the effect of cumulative operator experience on hepatocellular carcinoma recurrence after primary treatment with radiofrequency ablation. Radiology 276:294–301.
   PubMed Web of Science ®Google Scholar
• Lee KH, Piao H, Son BR, et al. (2004). Herpes simplex virus thymidine kinase and granulocyte macrophage colony-stimulating factor combination gene therapy in a murine CT26 cell colon cancer model. Cancer Gene Ther 11:570–6.
   PubMed Web of Science ®Google Scholar
• Palmer DH, Hussain SA, Johnson PJ. (2005). Gene- and immunotherapy for hepatocellular carcinoma. Exp Opin Biol Ther 2005;5:507–23.
   PubMed Web of Science ®Google Scholar
• Schuster MJ, Wu GY. (1997). Gene therapy for hepatocellular carcinoma: progress but many stones yet unturned! Gastroenterology 112:656–9.
   PubMed Web of Science ®Google Scholar
• Gerolami R, Uch R, Brechot C, et al. (2003). Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact. Cancer Gene Ther 10:649–60.
   PubMed Web of Science ®Google Scholar